Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences

Rhea-AI Summary

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announced participation in two upcoming virtual investor conferences. Management will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 20, 2021, at 2:55 pm ET, and at the Cantor Global Healthcare Conference on September 30, 2021, at 12:40 pm ET. Interested parties can access webcasts via the Aurinia website, where replays will also be available. The company focuses on treating serious diseases with high unmet medical needs, notably introducing an FDA-approved therapy for lupus nephritis.

VICTORIA, British Columbia--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that members of the senior management team will present at the following upcoming virtual investor conferences:

• Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Monday, September 20, 2021 at 2:55 pm ET. (access here)
• Cantor Global Healthcare Conference on September 30, 2021 at 12:40 pm ET. (access here)

In order to participate in the audio webcasts, interested parties can also register and access presentations under "News/Events” through the “Investors” section of the Aurinia corporate website at www.auriniapharma.com. A replay of the webcasts will be available on Aurinia’s website.

ABOUT AURINIA

Aurinia is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company recently introduced the first FDA-approved oral therapy indicated for the treatment of adult patients with active lupus nephritis (LN). Aurinia’s head office is in Victoria, British Columbia; its U.S. commercial hub is in Rockville, Maryland; and the Company focuses development efforts globally.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210915005149/en/

Investor and Corporate Contact:

Dana Lynch, Corporate Communications & IR

dlynch@auriniapharma.com

Source: Aurinia Pharmaceuticals Inc.

FAQ

When is Aurinia Pharmaceuticals participating in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit?

Aurinia Pharmaceuticals will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 20, 2021, at 2:55 pm ET.

What date will Aurinia present at the Cantor Global Healthcare Conference?

Aurinia Pharmaceuticals is scheduled to present at the Cantor Global Healthcare Conference on September 30, 2021, at 12:40 pm ET.

How can I access the webcasts for Aurinia Pharmaceuticals' investor conferences?

Webcasts for Aurinia Pharmaceuticals' investor conferences can be accessed through the 'News/Events' section on their official website.

What is the focus of Aurinia Pharmaceuticals as a biopharmaceutical company?

Aurinia Pharmaceuticals focuses on delivering therapies for serious diseases with high unmet medical needs, including a recently FDA-approved treatment for lupus nephritis.

What is the stock symbol for Aurinia Pharmaceuticals?

The stock symbol for Aurinia Pharmaceuticals is AUPH.